Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:781-788

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagrov, A. Y.
Right arrow Articles by Anderson, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagrov, A. Y.
Right arrow Articles by Anderson, D. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OUABAIN

(Hypertension. 1995;26:781.)
© 1995 American Heart Association, Inc.


Articles

Endogenous Marinobufagenin-like Immunoreactive Factor and Na+,K+ ATPase Inhibition During Voluntary Hypoventilation

Presented in part at the XV European Section Meeting of the International Society for Heart Research, Copenhagen, Denmark, June 8-11, 1994.

Alexei Y. Bagrov; Olga V. Fedorova; Joy L. Austin-Lane; Renata I. Dmitrieva; David E. Anderson

From the Laboratory of Behavioral Sciences (A.Y.B., O.V.F., J.L.A.-L., D.E.A.), National Institute on Aging, 4940 Eastern Ave, Baltimore, Md, and the Laboratory of Pharmacology (A.Y.B., O.V.F., R.I.D.), Sechenov Institute of Evolutionary Physiology and Biochemistry, St Petersburg, Russia.

Correspondence to Dr Alexei Y. Bagrov, Laboratory of Behavioral Sciences, National Institute on Aging, 4940 Eastern Ave, Baltimore, MD 21224.

Abstract In previous studies investigators found that conditioned hypoventilatory breathing potentiated a sodium-sensitive form of hypertension in dogs that was not mediated by sympathetic nervous system arousal. Our study investigated effects of 30 minutes of voluntary hypoventilation, maintained by a respiratory gas monitor and feedback procedure, in 16 normotensive humans of both sexes on (1) plasma concentrations of endogenous digitalis-like factors (ouabain-like and marinobufagenin-like immunoreactivity), (2) activity of erythrocyte Na+,K+-ATPase, (3) inhibitory activity of plasma Na+,K+-ATPase, and (4) blood pressure. Increased end tidal PCO2 (41±0.78 mm Hg versus 37.6±1.03 mm Hg) was associated with (1) an increase in plasma marinobufagenin-like immunoreactivity (1.23±0.47 versus 4.96±1.19 nmol/L), (2) an inhibition of Na+,K+-ATPase in red blood cells (3.68±0.22 versus 2.15±0.25 mmol Pi · mL-1 · h-1; P<.01), (3) increase in plasma Na+,K+-ATPase inhibitory activity (34.9±4.0% versus 48.8±2.1%, P<.02), and (4) increases in systolic (112.4±2.6 versus 107.6±1.8 mm Hg) and diastolic (73.5±2.1 versus 68.8±2.1 mm Hg) blood pressures. Plasma levels of ouabain-like immunoreactivity did not increase significantly. Incubation of erythrocytes obtained during hypoventilation with antidigoxin antibody restored the Na+,K+-ATPase activity (3.99±0.34 mmol Pi · mL-1 · h-1). Cessation of hypoventilation was associated with decreases in diastolic blood pressure (70.5±2.2 mm Hg) and restoration of Na+,K+-ATPase activity in erythrocytes (2.99±0.43 mmol Pi · mL-1 · h-1). On the basis of organic extraction and thin-layer chromatography followed by separation with the use of reverse-phase high-performance liquid chromatography, the material coeluting with marinobufagenin was separated from human urine. This material cross-reacted with anti-marinobufagenin antibody. These results demonstrate the presence of a bufadienolide-like Na+,K+-ATPase inhibitor in human plasma and support the view that breathing pattern may participate in blood pressure control via release of a rapidly acting circulating Na+,K+-ATPase inhibitor.


Key Words: hypoventilation • Na+,K+-exchanging ATPase • bufanolides • hypertension




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Mandal, N. A. Delamere, and M. Shahidullah
Ouabain-induced stimulation of sodium-hydrogen exchange in rat optic nerve astrocytes
Am J Physiol Cell Physiol, July 1, 2008; 295(1): C100 - C110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. E. Anderson, O. V. Fedorova, C. H. Morrell, D. L. Longo, V. A. Kashkin, J. D. Metzler, A. Y. Bagrov, and E. G. Lakatta
Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1248 - R1254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Yoshika, Y. Komiyama, M. Konishi, T. Akizawa, T. Kobayashi, M. Date, S. Kobatake, M. Masuda, H. Masaki, and H. Takahashi
Novel Digitalis-Like Factor, Marinobufotoxin, Isolated From Cultured Y-1 Cells, and Its Hypertensive Effect in Rats
Hypertension, January 1, 2007; 49(1): 209 - 214.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Bauer, J. Muller-Ehmsen, U. Kramer, N. Hambarchian, C. Zobel, R. H.G. Schwinger, H. Neu, U. Kirch, E.-G. Grunbaum, and W. Schoner
Ouabain-Like Compound Changes Rapidly on Physical Exercise in Humans and Dogs: Effects of {beta}-Blockade and Angiotensin-Converting Enzyme Inhibition
Hypertension, May 1, 2005; 45(5): 1024 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Rosen, V. Glukhman, T. Feldmann, E. Fridman, and D. Lichtstein
Cardiac Steroids Induce Changes in Recycling of the Plasma Membrane in Human NT2 Cells
Mol. Biol. Cell, March 1, 2004; 15(3): 1044 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. A. El-Masri, B. J. Clark, H. M. Qazzaz, and R. Valdes Jr
Human Adrenal Cells in Culture Produce Both Ouabain-like and Dihydroouabain-like Factors
Clin. Chem., October 1, 2002; 48(10): 1720 - 1730.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. V. Fedorova, D. E. Anderson, E. G. Lakatta, and A. Y. Bagrov
Interaction of NaCl and behavioral stress on endogenous sodium pump ligands in rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R352 - R358.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. Scuteri, D. Parsons, M. A. Chesney, and D. E. Anderson
Anger Inhibition Potentiates the Association of High End-Tidal CO2 With Blood Pressure in Women
Psychosom Med, May 1, 2001; 63(3): 470 - 475.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Balzan, D. Neglia, S. Ghione, G. D'Urso, M. C. Baldacchino, U. Montali, and A. L'Abbate
Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction
Eur J Heart Fail, March 1, 2001; 3(2): 165 - 171.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. V. Fedorova, N. I. Kolodkin, N. I. Agalakova, E. G. Lakatta, and A. Y. Bagrov
Marinobufagenin, an Endogenous {{alpha}}-1 Sodium Pump Ligand, in Hypertensive Dahl Salt-Sensitive Rats
Hypertension, February 1, 2001; 37(2): 462 - 466.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
O. V. Fedorova, E. G. Lakatta, and A. Y. Bagrov
Endogenous Na,K Pump Ligands Are Differentially Regulated During Acute NaCl Loading of Dahl Rats
Circulation, December 12, 2000; 102(24): 3009 - 3014.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. H. McGowan, P. Russell, D. A. Carper, and D. Lichtstein
Na+, K+-ATPase Inhibitors Down-Regulate Gene Expression of the Intracellular Signaling Protein 14-3-3 in Rat Lens
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1559 - 1563.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Antolovic, H. Kost, M. Mohadjerani, D. Linder, M. Linder, and W. Schoner
A Specific Binding Protein for Cardiac Glycosides Exists in Bovine Serum
J. Biol. Chem., June 26, 1998; 273(26): 16259 - 16264.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Y. Bagrov, O. V. Fedorova, R. I. Dmitrieva, W. N. Howald, A. P. Hunter, E. A. Kuznetsova, and V. M. Shpen
Characterization of a Urinary Bufodienolide Na+,K+-ATPase Inhibitor in Patients After Acute Myocardial Infarction
Hypertension, May 1, 1998; 31(5): 1097 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. De Angelis and G. T. Haupert Jr.
Hypoxia triggers release of an endogenous inhibitor of Na+-K+-ATPase from midbrain and adrenal
Am J Physiol Renal Physiol, January 1, 1998; 274(1): F182 - F188.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Sich, U. Kirch, M. Tepel, W. Zidek, and W. Schoner
Pulse Pressure Correlates in Humans With a Proscillaridin A Immunoreactive Compound
Hypertension, May 1, 1996; 27(5): 1073 - 1078.
[Abstract] [Full Text]


Home page
CirculationHome page
O. V. Fedorova, M. I. Talan, N. I. Agalakova, E. G. Lakatta, and A. Y. Bagrov
Endogenous Ligand of {alpha}1 Sodium Pump, Marinobufagenin, Is a Novel Mediator of Sodium Chloride-Dependent Hypertension
Circulation, March 5, 2002; 105(9): 1122 - 1127.
[Abstract] [Full Text] [PDF]